These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 25532640)
1. In vitro antimicrobial analysis of aqueous humor after topical application of moxifloxacin hydrochloride 0.5%. de Miranda AP; Silva CB; Mimica LM; Moscovici BK; Malavazzi GR; Hida RY J Cataract Refract Surg; 2015 Jan; 41(1):135-9. PubMed ID: 25532640 [TBL] [Abstract][Full Text] [Related]
2. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. Donnenfeld ED; Comstock TL; Proksch JW J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251 [TBL] [Abstract][Full Text] [Related]
3. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Kim DH; Stark WJ; O'Brien TP; Dick JD Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. Odenholt I; Cars O J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293 [TBL] [Abstract][Full Text] [Related]
6. The effect of cataract surgery on ocular levels of topical moxifloxacin. Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae. Lemmen SW; Häfner H; Klik S; Lütticken R; Zolldann D Chemotherapy; 2003 May; 49(1-2):33-5. PubMed ID: 12714807 [TBL] [Abstract][Full Text] [Related]
8. Aqueous humor concentrations of topical fluoroquinolones alone or in combination with a steroid. Gomes RLR; Viana RG; Melo LAS; Cruz AC; Lima AAS; Suenaga EM; Campos M Arq Bras Oftalmol; 2017; 80(5):300-303. PubMed ID: 29160540 [TBL] [Abstract][Full Text] [Related]
9. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810 [TBL] [Abstract][Full Text] [Related]
10. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. McCulley JP; Caudle D; Aronowicz JD; Shine WE Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244 [TBL] [Abstract][Full Text] [Related]